[Proteinase inhibiting agents and glucagon in acute pancreatitis (author's transl)].
In two prospective studies the effect of proteinase inhibiting agents and glucagon in acute pancreatitis have been studied by a randomised series. Moreover the effect of the basic therapy was examined in additional 103 patients. Symptoms, clinical and laboratory chemical findings correspond to each other in all collectives. The results seem to be the best ones in those patients having been treated by basic therapy only.
D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D000437:Alcoholism / Q000150:complications; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D005934:Glucagon / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010195:Pancreatitis / Q000188:drug therapy*; D012737:Sex Factors; D014361:Trypsin Inhibitors / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D014361:Trypsin Inhibitors; D005934:Glucagon
Ergebnisse prospektiver Untersuchungen über den Wert der Proteinaseninhibitoren und des Glukagons bei der akuten Pankreatitis.